scispace - formally typeset
Open AccessJournal ArticleDOI

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Reads0
Chats0
TLDR
In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2.
About
This article is published in Cell.The article was published on 2021-04-29 and is currently open access. It has received 1109 citations till now. The article focuses on the topics: Vaccination & Humoral immunity.

read more

Citations
More filters
Journal ArticleDOI

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants

TL;DR: A lipid nanoparticle-encapsulated, nucleoside-unmodified mRNA (mRNA-LNP) vaccine encoding the trimerized receptor-binding domain (RBD trimer) showed its robust capability in inducing broad and protective immune responses against wild-type and major variants of concern (VOCs) in the mouse model of SARS-CoV-2 infection as mentioned in this paper .
Journal ArticleDOI

Dynamic of humoral response to SARS-CoV-2 anti Nucleocapsid and Spike proteins after CoronaVac vaccination

TL;DR: In this article, the authors measured the seroconversion rate and IgG antibody dynamic range of the CoronaVac vaccine after immunization in healthcare workers (HCWs) in Southern Brazil.
Journal ArticleDOI

Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2

TL;DR: In this article, the authors analyzed the appearance and prevalence trajectory over time of mutations that appeared in all SARS-CoV-2 genes from December 2019 to April 2021, and provided an integrative view of the emergence, disappearance, and consensus sequence integration of successful mutations that constitute new SARS CoV2 variants and their impact on neutralizing antibody therapeutics and vaccines.
References
More filters
Journal ArticleDOI

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Related Papers (5)